Skip to main content

FERINJECT (Vifor Pharma Pty Ltd)

Product name
FERINJECT
Date registered
Evaluation commenced
Decision date
Approval time
189 (255 working days)
Active ingredients
ferric carboxymaltose
Registration type
EOI
Indication

FERINJECT is indicated for the treatment of iron deficiency in adults and adolescents aged 14 years and older when:

  1. oral iron preparations are ineffective
  2. oral iron preparations cannot be used
  3. there is a clinical need to deliver iron rapidly

The diagnosis of iron deficiency must be based on laboratory tests.

FERINJECT is indicated for the treatment of iron deficiency anaemia in children aged 1 to 13 years when:

  1. oral iron preparations are ineffective
  2. oral iron preparations cannot be used

The diagnosis of iron deficiency anaemia must be based on laboratory tests.

Help us improve the Therapeutic Goods Administration site